Qi Sui Zhu Shui Plaster Inhibits AQP1 and MAPK Signaling Reduces Liver Damage Induced by Cirrhotic Ascites

Table 2

The changes in abdominal circumference (mm) during 15 weeks.

Time(week)	Con	Mod	QSZSP low dose	QSZSP high dose
2	86.82 ± 10.10	83.42 ± 6.08	83.97 ± 2.57	88.95 ± 5.24
2.5	97.93 ± 8.89	91.67 ± 7.76	91.50 ± 3.84	88.97 ± 7.59
3	107.78 ± 7.12	84.52 ± 8.14	92.47 ± 8.92	91.57 ± 9.15
3.5	116.95 ± 8.95	92.30 ± 7.04	94.78 ± 7.58	93.72 ± 9.83
4	130.27 ± 8.90	97.50 ± 7.68	104.23 ± 6.31	98.73 ± 9.81
4.5	150.05 ± 12.11	100.03 ± 7.61	106.33 ± 4.13	103.20 ± 15.95
5	144.35 ± 14.13	108.78 ± 10.27	110.85 ± 7.32	108.58 ± 15.77
5.5	142.02 ± 11.11	110.63 ± 10.71	115.10 ± 8.89	111.40 ± 17.23
6	157.02 ± 9.70	109.18 ± 9.64	119.68 ± 10.69	115.10 ± 14.29
6.5	154.47 ± 13.95	116.42 ± 14.45	116.17 ± 8.02	112.65 ± 13.56
7	149.68 ± 8.13	114.72 ± 16.26	120.90 ± 11.55	114.57 ± 20.11
7.5	165.20 ± 12.73	124.82 ± 16.89	123.07 ± 12.84	118.77 ± 16.80
8	171.13 ± 7.42	125.50 ± 14.24	123.18 ± 9.90	120.28 ± 13.06
8.5	168.32 ± 22.96	136.28 ± 13.62	141.88 ± 11.82	124.18 ± 14.54
9	166.77 ± 25.63	137.53 ± 11.23	139.52 ± 6.78	128.63 ± 15.32
9.5	175.60 ± 19.28	137.00 ± 9.18	145.05 ± 6.80	127.73 ± 16.29
10	162.43 ± 13.10	140.27 ± 17.08	142.58 ± 9.35	134.80 ± 15.86
10.5	167.73 ± 12.37	143.18 ± 17.91	137.97 ± 15.70	132.43 ± 11.86
11	170.40 ± 17.75	133.67 ± 16.74	129.23 ± 13.34	135.38 ± 8.86
11.5	174.67 ± 16.79	131.15 ± 12.09	139.08 ± 15.77	130.03 ± 21.11
12	176.17 ± 18.18	131.75 ± 20.23	142.13 ± 18.74	137.10 ± 17.83
12.5	183.68 ± 16.49	132.83 ± 11.32	130.85 ± 19.06	135.52 ± 15.62
13	190.35 ± 20.90	155.17 ± 17.92	153.37 ± 12.49	149.97 ± 14.59
14	192.75 ± 16.63	170.27 ± 20.43	164.73 ± 11.44	161.17 ± 16.53
15	211.00 ± 14.26	198.93 ± 6.09	181.20 ± 8.63	177.73 ± 18.77
16	214.10 ± 17.34	213.80 ± 3.89	189.43 ± 7.17	185.03 ± 17.42

Data presented as mean ± standard deviation.